Acute lymphoblastic leukemia diagnostic study of choice

Jump to: navigation, search

Acute lymphoblastic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute lymphoblastic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Bone X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute lymphoblastic leukemia diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute lymphoblastic leukemia diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute lymphoblastic leukemia diagnostic study of choice

CDC on Acute lymphoblastic leukemia diagnostic study of choice

Acute lymphoblastic leukemia diagnostic study of choice in the news

Blogs on Acute lymphoblastic leukemia diagnostic study of choice

Directions to Hospitals Treating Acute lymphoblastic leukemia

Risk calculators and risk factors for Acute lymphoblastic leukemia diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Shyam Patel [2]

Overview

The diagnostic study of choice for acute lymphoblastic lymphoma is bone marrow biopsy.

Diagnostic study of choice

Diagnostic results

On bone marrow biopsy the following result is a confirmation of acute lymphoblastic leukemia:

Sequence of Diagnostic Studies

The various investigations must be performed in the following order:

References

  1. Thomas X, Le QH, Danaïla C, Lhéritier V, Ffrench M (October 2002). "Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors". Leuk. Res. 26 (10): 909–18. PMID 12163052.
  2. Kröber SM, Greschniok A, Kaiserling E, Horny HP (April 2000). "Acute lymphoblastic leukaemia: correlation between morphological/immunohistochemical and molecular biological findings in bone marrow biopsy specimens". MP, Mol. Pathol. 53 (2): 83–7. PMC 1186910. PMID 10889907.
  3. Chiaretti S, Zini G, Bassan R (2014). "Diagnosis and subclassification of acute lymphoblastic leukemia". Mediterr J Hematol Infect Dis. 6 (1): e2014073. doi:10.4084/MJHID.2014.073. PMC 4235437. PMID 25408859.
  4. Terwilliger T, Abdul-Hay M (2017). "Acute lymphoblastic leukemia: a comprehensive review and 2017 update". Blood Cancer J. 7 (6): e577. doi:10.1038/bcj.2017.53. PMC 5520400. PMID 28665419.

Linked-in.jpg